SIIPL Tdap IPV
Alternative Names: SIIPL Tdap-IPV - Serum Institute of India; SIIPL Tdap-IPV vaccine; Tetanus, Diphtheria, Acellular Pertussis and Poliomyelitis Vaccine - Serum Institute of IndiaLatest Information Update: 06 Oct 2020
At a glance
- Originator Serum Institute of India
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Diphtheria; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 07 Jul 2020 Phase-I/II clinical trials in Diphtheria (In children, In adolescents, In adults, Prevention) in Australia (IM) (ACTRN12620000848909)
- 07 Jul 2020 Phase-I/II clinical trials in Pertussis (In children, In adolescents, In adults, Prevention) in Australia (IM) (ACTRN12620000848909)
- 07 Jul 2020 Phase-I/II clinical trials in Poliomyelitis (In children, In adolescents, In adults, Prevention) in Australia (IM) (ACTRN12620000848909)